SEC Filings
APi Group Raises 2026 Revenue Outlook To $9.2 Billion After Specialty Sales Jump 30.7%
The fire-safety contractor lifted its full-year sales and adjusted EBITDA ranges, though gross margin slipped 120 basis points to 30.1%.
SEC Filings
The fire-safety contractor lifted its full-year sales and adjusted EBITDA ranges, though gross margin slipped 120 basis points to 30.1%.
SEC Filings
Chief Credit Officer Troy Remington steps in as interim risk chief while the bank searches for a permanent successor.
SEC Filings
The breast-implant maker raised its 2026 revenue outlook to more than $274 million, though it still lost $10.7 million in the quarter.
SEC Filings
The uranium enrichment company also says it has locked in a full domestic supply chain, with new Ohio capacity still expected in 2029.
SEC Filings
Holders of the older notes can convert this quarter; Integer says it would refinance any conversion with its revolving credit line.
SEC Filings
A temporary conversion right tied to the dividend flipped the notes to a current liability and left a $501 million working capital deficit.
SEC Filings
The contractor also took a $34.0 million writedown on a building services business as nine 2026 deals carried $809.9 million upfront.
SEC Filings
The exchange would trim debt principal by about $53 million and move $121 million of maturities from 2028 to 2030, the company said.
SEC Filings
The experimental antibody, paired with toripalimab and chemotherapy, showed a 75% confirmed response rate in a small interim cohort.
SEC Filings
Vanda also lost its HETLIOZ patent suits in Delaware and set a November 2027 generic entry date for Fanapt, its 10-Q shows.
SEC Filings
The seller note ran above the $320.0 million to $340.0 million range PBF gave in July, as the refiner retired $1.3 billion of notes.
SEC Filings
The cash floor on Phathom's royalty financing rose from $30 million on October 1, while generic-drug filers challenge its exclusivity.